A carregar...
Synthesis of Novel Analogs of Cabergoline: Improving Cardiovascular Safety by Removing 5-HT(2B) Receptor Agonism
[Image: see text] The dopamine agonist cabergoline has been used to treat prolactinomas, Parkinson’s disease, Cushing’s disease, and sexual dysfunction. However, its clinical use was severely curtailed when it was found that patients taking cabergoline had an increased risk of developing cardiac-val...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American
Chemical Society
2013
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3629922/ https://ncbi.nlm.nih.gov/pubmed/23606928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml3003814 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|